A cutting-edge LC-MS/MS methodology reduces sequence variant analysis timelines from 6–8 weeks to 1–2 weeks, ensuring absence of genetic mutations during cell culture.
Why Sequence Variants Matter
Unintended amino acid changes can affect safety and efficacy and must be controlled.
Faster LC-MS/MS Workflows
Streamlined sample preparation and analysis cut turnaround from weeks to days.
Supporting Cell Line Selection
Quicker results speed clone selection and reduce program risk.
About This White Paper
This white paper is published by Samsung Biologics and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.